GlassScriptPhysician profile
Frederick B Lintecum
NPI 1841299823
$2,755.12
in general payments reported to CMS, 2019-2025
26 companies · $14.73 in 2025
The $14.73 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $628 · 2021: $788 · 2022: $540 · 2023: $294 · 2024: $96.97 · 2025: $14.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $684.86 | 2019-2024 | |
| Pfizer INC. | $461.82 | 2019-2023 | |
| Daiichi Sankyo INC. | $394.12 | 2019-2023 | Injectafer |
| Amgen INC. | $220.63 | 2020-2023 | Prolia, Evenity |
| Currax Pharmaceuticals LLC | $200.82 | 2019-2022 | |
| Therapeuticsmd, INC. | $101.30 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.77 | 2019-2021 | |
| Medtronic, INC. | $81.93 | 2024-2025 | Ligasure, Endo Stitch, Rapidvac |
| Astellas Pharma US INC | $73.27 | 2023 | Veozah, Myrbetriq |
| Allergan, INC. | $55.82 | 2019-2020 | |
| Novo Nordisk INC | $46.53 | 2019-2024 | Wegovy |
| Evofem Biosciences, INC. | $46.29 | 2021 | |
| Mylan Pharmaceuticals INC. | $44.48 | 2020-2021 | |
| Exeltis, USA INC. | $43.21 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $37.19 | 2021-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $22.55 | 2020-2021 | |
| Organon LLC | $18.49 | 2022 | |
| Scynexis, INC. | $18.20 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.67 | 2019 | |
| Gynesonics, INC. | $16.41 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $16.15 | 2022 | |
| Bausch Health US, LLC | $16.09 | 2020 | |
| Agile Therapeutics, INC. | $14.12 | 2021 | |
| Merck Sharp & Dohme LLC | $13.86 | 2019 | |
| Eisai INC. | $12.86 | 2019 | |
| Lupin INC. | $12.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Lintecum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.